SCHEMBL380478

SCHEMBL380478

CCC/C=C\C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL380479 1.00
SCHEMBL28009889 1.00 TAS1R3 (0.47)
SCHEMBL872905 1.00
SCHEMBL10690892 0.97
SCHEMBL10366501 0.95 PPARA (0.44)
SCHEMBL10366503 0.95 PPARA (0.44)
Hydrochloric Acid SCHEMBL8018515 0.95 TAS1R3 (0.44)
Hydrochloric Acid SCHEMBL8925660 0.95 TAS1R3 (0.44)
Hydrochloric Acid SCHEMBL29469612 0.93 PPARA (0.42)
SCHEMBL8400754 0.91 TAS1R3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118243835-A Method for identifying aloe ferment flavor under different fermentation processes based on metabonomics 浙江工业大学 2024-06-25 CN disclosed
CN-110382451-A Transfer hydrogenation process 伊士曼化工公司 2019-10-25 CN disclosed
CN-110088117-A Novel compounds like quercetol 株式会社爱茉莉太平洋 2019-08-02 CN disclosed
CN-109863159-A The new kaempferia galanga phenolic compound in post-fermented tea source 株式会社爱茉莉太平洋 2019-06-07 CN disclosed
CN-109843087-A Cognitive function improving composition comprising novel post-fermented tea derived kaempferol compounds 株式会社爱茉莉太平洋 2019-06-04 CN disclosed
CN-105585601-B Anti-aging skin external composition and preparation method thereof 株式会社林原 2018-11-13 CN disclosed
CN-108697687-A Composition for improving cognitive function comprising 3-O-galloyl-3,3',5,5',7-pentahydroxyflavan 株式会社爱茉莉太平洋 2018-10-23 CN disclosed
CN-108697143-A Including 3-O- galloyls -3,3 ', the Hydra composition of 5,5 ', 7- penta hydroxy group flavane 株式会社爱茉莉太平洋 2018-10-23 CN disclosed
US-9358191-B2 Deodorant composition TAKASAGO INTERNATIONAL CORPORATION (JP) 2016-06-07 US disclosed
CN-105585601-A Anti-aging skin external composition and preparation method thereof HAYASHIBARA CO 2016-05-18 CN disclosed
WO-2002088753-A1 INDIVIDUALIZATION OF THERAPY WITH ERECTILE DYSFUNCTION AGENTS MCGILL UNIVERSITY (CA) 2002-11-07 WO disclosed
WO-2002088714-A2 INDIVIDUALIZATION OF THERAPY WITH ANTINEOPLASTIC AGENTS MCGILL UNIVERSITY (CA) 2002-11-07 WO disclosed
WO-2002086504-A2 INDIVIDUALIZATION OF THERAPY WITH GASTROESOPHAGEAL REFLUX DISEASE AGENTS MCGILL UNIVERSITY (CA) 2002-10-31 WO disclosed
WO-2002084288-A2 INDIVIDUALIZATION OF THERAPY WITH ANTIARRHYTHMICS MCGILL UNIVERSITY (CA) 2002-10-24 WO disclosed
WO-2002073197-A2 INDIVIDUALIZATION OF THERAPY WITH ANTIDEPRESSANTS MCGILL UNIVERSITY (CA) 2002-09-19 WO disclosed
WO-2002073196-A2 INDIVIDUALIZATION OF THERAPY WITH ANTIPSYCHOTICS MCGILL UNIVERSITY (CA) 2002-09-19 WO disclosed
WO-2002073206-A2 METABOLIC PHENOTYPING IN THERAPY WITH ANXIOLYTICS MCGILL UNIVERSITY (CA) 2002-09-19 WO disclosed
WO-2002073205-A2 METABOLIC PHENOTYPING IN THERAPY WITH IMMUNOSUPPRESSANTS MCGILL UNIVERSITY (CA) 2002-09-19 WO disclosed
WO-2002071060-A2 USE OF METABOLIC PHENOTYPING IN INDIVIDUALIZED TREATMENT WITH AMONAFIDE MCGILL UNIVERSITY (CA) 2002-09-12 WO disclosed
WO-2002008164-A1 SECONDARY C10-18 SURFACTANT ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2002-01-31 WO disclosed